格隆汇2月9日丨方大炭素(600516.SH)公布，为优化库存管理，整合公司及子公司物流环节的管控效率 与稳定性，提升公司抗风险能力，降低储运及物流成本，公司拟以自有资金购买关联方天津一商持有的 天津通达环宇物流有限公司（以下简称标的公司）100%股权。上述股权评估价值为31,918.70万元，根 据交易双方协商，交易对价拟定为31,918.70万元。 ...

格隆汇2月9日丨金瑞矿业(600714.SH)公布，公司于2026年2月9日收到李健发来的《关于减持股份暨减 持后持股比例降至5%以下的告知函》及《简式权益变动报告书》。李健于2026年2月2日至2026年2月6 日通过集中竞价交易方式减持公司股份87万股。本次权益变动后，李健持有公司股份数量由15,276,629 股减少至14,406,629股，持股比例由5.3011%下降至4.9992%，跨越5%刻度。 ...

Core Viewpoint - ST Changfang (300301.SZ) has received the "High-tech Enterprise Certificate" from the Jiangxi Provincial Department of Science and Technology, Jiangxi Provincial Department of Finance, and the State Taxation Administration of Jiangxi Province, which allows the company to enjoy tax benefits for three years [1] Group 1 - The certificate number is GR202536001668, issued on December 2, 2025, and is valid for three years [1] - Upon receiving the high-tech enterprise recognition, Jiangxi Changfang Semiconductor Technology Co., Ltd. will benefit from tax incentives as per the Corporate Income Tax Law of the People's Republic of China [1]

格隆汇2月9日丨姚记科技(002605.SZ)公布，公司股票价格自2025年12月26日至2026年2月9日，已有十 五个交易日的收盘价不低于当期转股价格(即20.06元/股)的130%(即26.08元/股)。根据《上海姚记科技股 份有限公司向不特定对象发行可转换公司债券募集说明书》的约定，已触发"姚记转债"有条件赎回条 款。 公司于2026年2月9日召开第六届董事会第二十五次会议，审议通过了《关于不提前赎回"姚记转债"的议 案》。公司董事会决定本次不行使"姚记转债"的提前赎回权利，且在未来三个月内(自2026年2月10日至 2026年5月9日)"姚记转债"再次触发有条件赎回条款时，公司均不行使提前赎回权利。自2026年5月9日 后首个交易日重新计算，若"姚记转债"再次触发上述有条件赎回条款，届时董事会将另行召开会议决定 是否行使"姚记转债"的提前赎回权利。 ...

格隆汇2月9日丨宣泰医药(688247.SH)公布，公司于2026年2月9日收到Finer出具的《关于上海宣泰医药 科技股份有限公司股份减持计划的告知函》，因股东自身资金需求，Finer计划根据市场情况拟通过集 中竞价或大宗交易的方式减持其所持有的公司股份数量合计不超过906.68万股，拟减持股份数量占公司 总股本的比例不超过2.0000%。其中以集中竞价方式减持的，减持期间为本公告披露之日起15个交易日 后的3个月内；以大宗交易方式减持的，减持期间为本公告披露之日起15个交易日后的3个月内。减持价 格按市场价格确定。 ...

格隆汇2月9日丨步长制药(603858.SH)公布，山东步长冠优医疗器械有限公司（以下简称"步长冠优"） 为公司控股子公司，公司持有其90%股权，谢继辉持有其4%股权，何涛持有其2%股权，罗文清、于海 铭、魏齐文、刘安安各持有其1%股权。 公司于2026年2月6日召开第五届董事会第四十三次会议，审议通过了《关于控股子公司股权转让暨放弃 优先受让权的议案》，刘安安拟将其所持有的步长冠优1%未实缴股权以人民币0元的价格转让给朱彬 彬。公司同意放弃优先受让权，交易完成后，公司持有步长冠优90%股权比例不变。 ...

Group 1 - The core point of the article is that Jianfa Co., Ltd. (600153.SH) is expanding its supply chain operations by collaborating with potential excellent enterprises in the consumer sectors such as catering, food, and home appliances [1] - Jianfa's wholly-owned subsidiary, Jianfa Living Materials, has signed a partnership agreement with Chengqi Investment to invest in a fund aimed at consumer industry enterprises in China [1] - The investment amount from Jianfa Living Materials as a limited partner (LP) is set at 18 million yuan, which will be used to subscribe to shares of the Qicheng Fund initiated by Chengqi Investment as the general partner [1]

Core Viewpoint - He Sheng New Materials (002290.SZ) announced that former director Wu Haifeng has increased his shareholding through competitive trading, acquiring a total of 252,100 shares, which represents 0.1016% of the company's total share capital, at an average transaction price of 39.68 yuan per share, amounting to a total investment of 10.0033 million yuan. This increase has reached and exceeded the lower limit of the planned share buyback, completing Wu Haifeng's buyback plan [1]. Summary by Category - Shareholding Increase: Wu Haifeng has cumulatively increased his shareholding by 252,100 shares, accounting for 0.1016% of the total share capital [1]. - Transaction Details: The average transaction price was 39.68 yuan per share, with a total transaction amount of 10.0033 million yuan [1]. - Completion of Buyback Plan: The share increase has met and surpassed the lower limit of the planned buyback, indicating the completion of Wu Haifeng's buyback plan [1].

Core Viewpoint - GCL-Poly Energy (002015.SZ) has announced the completion of its fundraising project "Shizhu Qiyaoshan Yulong Wind Power Phase II Project," which has reached the predetermined usable status [1] Summary by Categories Project Completion - The company has decided to conclude the fundraising project after confirming its operational status [1] - The remaining funds from the fundraising, after deducting the outstanding contract payments and warranty funds, will be fully utilized [1] Financial Status - As of December 31, 2025, the net amount of the fundraising account, after deducting interest income and handling fees, is -0.07 thousand yuan [1]

Core Viewpoint - The company TianKang Biological (002100.SZ) announced a share buyback plan with a total fund not exceeding RMB 200 million and not less than RMB 100 million [1] Group 1: Buyback Details - The buyback will be conducted through centralized bidding and will involve the company's A-shares [1] - The maximum buyback price is set at RMB 36.91 per share, which allows for an estimated repurchase of approximately 5.4186 million shares, accounting for about 0.25% of the company's total share capital based on the maximum fund [1] - If the minimum fund of RMB 100 million is utilized, the estimated repurchase would be around 2.7093 million shares, representing about 0.13% of the total share capital [1] Group 2: Timeline and Purpose - The buyback period will not exceed twelve months from the date the board of directors approves the buyback plan [1] - The repurchased shares will be used for future implementation of equity incentive plans and employee stock ownership plans [1]